TRVN stock results show that Trevena beat analyst estimates for earnings per share the second quarter of 2024. More
Articles
VERV Stock Earnings: Verve Therapeutics Beats EPS, Beats Revenue for Q2 2024
VERV stock results show that Verve Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
STER Stock Earnings: Sterling Check Misses EPS, Beats Revenue for Q2 2024
STER stock results show that Sterling Check missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. More
ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q2 2024
ITOS stock results show that ITeos Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. More
PASG Stock Earnings: Passage Bio Beats EPS for Q2 2024
PASG stock results show that Passage Bio beat analyst estimates for earnings per share the second quarter of 2024. More
FHTX Stock Earnings: Foghorn Therapeutics Beats EPS, Beats Revenue for Q2 2024
FHTX stock results show that Foghorn Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
SYBX Stock Earnings: Synlogic Beats EPS for Q2 2024
SYBX stock results show that Synlogic beat analyst estimates for earnings per share the second quarter of 2024. More
